Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketofol vs Propofol for ECT Seizure Duration
NCT05408000Completed
- Sponsor
- Tribhuvan University Teaching Hospital
- Start
- Jan 2021
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ketamine in major depressive disorder (MDD) and psychiatric disorders (2 arms), sponsored by Tribhuvan University Teaching Hospital. Primary endpoint: Motor Seizure Duration. Started Jan 2021; status: completed.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)psychiatric disorders
Beyond the preview
Go deeper on NCT05408000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05408000.